| 发明名称 |
COMBINATION OF A PD-1 ANTAGONIST AND AN IDO1 INHIBITOR FOR TREATING CANCER |
| 摘要 |
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a selective inhibitor of indoleamine 2, 3-dioxygenase 1 (IDO1), and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1. |
| 申请公布号 |
WO2015119944(A1) |
申请公布日期 |
2015.08.13 |
| 申请号 |
WO2015US14247 |
申请日期 |
2015.02.03 |
| 申请人 |
INCYTE CORPORATION;MERCK SHARP AND DOHME CORP.;LEOPOLD, LANCE;KAUFMAN, DAVID |
发明人 |
LEOPOLD, LANCE;KAUFMAN, DAVID |
| 分类号 |
A61K39/395 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
